Miyoshi myopathy (MM) is an adult onset, recessive inherited distal muscular dystrophy that we have mapped to human chromosome 2p13. We recently constructed a 3-Mb P1-derived artificial chromosome (PAC) contig spanning the MM candidate region. This clarified the order of genetic markers across the MM locus, provided five new polymorphic markers within it and narrowed the locus to approximately 2 Mb. Five skeletal muscle expressed sequence tags (ESTs) map in this region. We report that one of these is located in a novel, full-length 6.9-kb muscle cDNA, and we designate the corresponding protein 'dysferlin'. We describe nine mutations in the dysferlin gene in nine families; five are predicted to prevent dysferlin expression. Identical mutations in the dysferlin gene can produce more than one myopathy phenotype (MM, limb girdle dystrophy, distal myopathy with anterior tibial onset).
Access optionsAccess options
Subscribe to Journal
Get full journal access for 1 year
only $18.75 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Hoffman, E. Clinical and histopathological features of abnormalities of the dystrophin-based membrane cytoskeleton. Brain Pathol. 6, 49–61 (1996).
Brown, R.J. Dystrophin-associated proteins and the muscular dystrophies. Annu. Rev. Med. 48, 457–466 ( 1997).
Bonnemann, C., McNally, E. & Kunkel, L. Beyond dystrophin: current progress in the muscular dystrophies. Curr. Opin. Pediatr. 8, 569 –582 (1996).
Miyoshi, M., Kawai, H., Iwasa, M., Kuska, K. & Nishino, H. Autosomal recessive distal muscular dystrophy as a new type of progressive muscular dystrophy. Brain 109, 31–54 (1986).
Bejaoui, K. et al. Linkage of Miyoshi myopathy (distal autosomal recessive muscular dystrophy) locus to chromosome 2p12-13. Neurology 45 , 768–772 (1995).
Bejaoui, K. et al. Genetic fine mapping of the Miyoshi myopathy locus and exclusion of eight candidate genes. Neurogenetics 1, 189-196 (1998).
Bashir, R. et al. A gene for autosomal recessive limb-girdle muscular dystrophy maps to chromosome 2p. Hum. Mol. Genet. 3, 455–457 (1994).
Bashir, R. et al. Genetic and physical mapping at the limb-girdle muscular dystrophy locus (LGMD2B) on chromosome 2p. Genomics 33, 46–52 (1996).
Passos-Bueno, M. et al. Confirmation of the 2p locus for the mild autosomal recessive limb-girdle muscular dystrohy gene (LGMD2B) in three families allows refinement of the candidate region. Genomics 27, 192 –195 (1995).
Weiler, T. et al. Limb-girdle muscular dystrophy and Miyoshi myopathy in an aboriginal Canadian kindred map to LGMD2B and segregate with the same haplotype. Am. J. Hum. Genet. 59, 872– 878 (1996).
Illarioshkin, S. et al. Refined genetic location of the chromosome 2p-linked progressive muscular dystrophy gene. Genomics 42, 345–348 (1997).
Liu, J. et al. Generation of a 3-Mb PAC contig spanning the Miyoshi myopathy/limb girdle muscular dystrophy (MM/LGMD2B) locus on chromosome 2p13. Genomics 49, 23–29 (1998).
Hudson, T. et al. An STS-based map of the human genome. Science 270, 1945–1954 ( 1995).
Hudson, T. et al. Isolation and chromosomal assignment of 100 highly informative human simple sequence repeat polymorphisms. Genomics 13, 622–629 (1992).
Gastier, J. et al. Survey of trinucleotide repeats in the human genome: assessment of their utility as genetic markers. Hum. Mol. Genet. 4, 1829–1836 (1995).
Schuler, G. et al. A gene map of the human genome. Science 274, 540–546 (1996).
Kozak, M. An analysis of 5´-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res. 15, 8125– 8133 (1987).
Kozak, M. The scanning model for translation: an update. J. Cell Biol. 108, 229–241 (1989).
Argon, Y. & Ward, S. Caenorhabditis elegans fertilization-defective mutants with abnormal sperm. Genetics 96, 413–433 (1980).
Achanzar, W. & Ward, S. A nematode gene required for sperm vesicle fusion. J. Cell Sci. 110, 1073– 1081 (1997).
Ward, S., Argon, Y. & Nelson, G. Sperm morphogenesis in wild-type and fertilization-defective mutants of Caenorhabditis elegans. J. Cell Biol. 91, 26–44 (1981).
Rizo, J. & Südhof, T. C2-domains, structure and function of a universal Ca+-binding domain. J. Biol. Chem. 273 , 15882–15897 (1998).
Nishizuka, Y. The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature 334, 661– 665 (1988).
Orita, S. et al. Doc2: a novel brain protein having two repeated C2-like domains. Biochem. Biophys. Res. Comm. 206, 439– 448 (1995).
Sakaguchi, G., Orita, S., Maeda, M., Igarashi, H. & Takai, Y. Molecular cloning of an isoform of Doc2 having two C2-like domains. Biochem. Biophys. Res. Comm. 217, 1053–1061 (1995).
Sudhof, T. & Rizo, J. Synaptotagmins: C2-domain proteins that regulate membrane traffic. Neuron 17, 379–388 (1996).
Henry, M. & Campbell, K. Dystroglycan: an extracellular matrix receptor linked to the cytoskeleton. Curr. Opin. Cell Biol. 8, 625–631 ( 1996).
Straub, V. & Campbell, K. Muscular dystrophies and the dystrophin-glycoprotein complex. Curr. Opin. Neurol. 10, 168– 175 (1997).
Hayashi, Y. et al. Mutations in the integrin α7 gene cause congenital myopathy. Nature Genet. 19, 94–97 (1998).
Richard, I. et al. Mutations in the proteolytic gene calpain 3 cause limb girdle muscular dystrophy type 2A. Cell 81, 27– 40 (1995).
Schon, E.A. & DiMauro, S. Mitochondrial DNA mutations and pathogenesis. J. Bioenerg. Biomembr. 29, 131–149,.
Haravuori, H. et al. Assignment of the tibial muscular dystrophy locus to chromosome 2q31. Am. J. Hum. Genet. 62, 620– 626 (1998).
Sambrook, J., Fritsch, F. & Maniatis, T. Molecular Cloning: A Library Manual (Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, 1989).
Benes, V., Kilger, C., Voss, H., Pääbo, S. & Ansorge, W. Direct primer walking on P1 plasmid DNA. Biotechniques 23, 98–100 (1997).
Aoki, M. et al. Mutations in the glutamate transporter EAAT2 gene do not cause abnormal EAAT2 transcripts in amyotrophic lateral sclerosis. Ann. Neurol. 43, 645–653 ( 1998).
The Cecil B. Day Investment Company and the Muscular Dystrophy Association funded many aspects of this project. R.B. is supported by NIH grants 5PO1AG12992, 5RO1N834913A and 5PO1NS31248. J.L. was funded by a post-doctoral fellowship of the Medical Research Council of Canada. M.A. received a stipend from the Muscular Dystrophy Association and the Pierre L de Bourgknecht Fund for ALS Research. P. de J. is supported by NIH (NIHGRI) grant 5RO1 HG1165 and U.S. Department of Energy grant DE-FCO3-96ER62294. E.S. is funded by the Canadian Genome Analysis and Technology Program. B.A.H. and K.J.B. were recipients respectively of NRSA fellowship IF32N10064 and a stipend from the Deater Foundation. I.I. and C.S. received grants from the Fondo Investigationes Sanitarias (F.I.S. 96/0863 and 98/5065 B.A.E.). C.A. is funded by grants from Telethon 916C and C19 and from a Finalized Research Grant 559/01/95 of Veneto Region. K.A. is supported by the Ministry of Health and Welfare (Japan) grants for the Center of Excellence and Brain Sciences. J.U. and M.F. are supported by the AFM, which funded family DNA collections in France; M.F. is also funded by Inserm (U153). We are grateful to L. Hayward for discussions of the predicted properties of dysferlin.
About this article
Journal of Molecular Histology (2019)
Annals of Clinical Neurophysiology (2019)
Disease duration and disability in dysfeRlinopathy can be described by muscle imaging using heatmaps and random forests
Muscle & Nerve (2019)
Journal of Cellular and Molecular Medicine (2019)